Axsome Therapeutics Stock Forecast - Polynomial Regression

AXSM Stock  USD 71.17  1.91  2.61%   
The Polynomial Regression forecasted value of Axsome Therapeutics on the next trading day is expected to be 70.47 with a mean absolute deviation of  3.44  and the sum of the absolute errors of 209.89. Axsome Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Axsome Therapeutics stock prices and determine the direction of Axsome Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Axsome Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Axsome Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Axsome Therapeutics' systematic risk associated with finding meaningful patterns of Axsome Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Axsome Therapeutics to cross-verify your projections.
To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.
  
At this time, Axsome Therapeutics' Payables Turnover is very stable compared to the past year. As of the 24th of April 2024, Fixed Asset Turnover is likely to grow to 43.62, while Inventory Turnover is likely to drop 1.35. . As of the 24th of April 2024, Common Stock Shares Outstanding is likely to drop to about 30.1 M. In addition to that, Net Loss is likely to grow to about (160 M).

Open Interest Against 2024-05-17 Axsome Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Axsome Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Axsome Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Axsome Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Axsome Therapeutics' open interest, investors have to compare it to Axsome Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Axsome Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Axsome. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Axsome Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Axsome Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Axsome Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Axsome Therapeutics polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Axsome Therapeutics as well as the accuracy indicators are determined from the period prices.

Axsome Therapeutics Polynomial Regression Price Forecast For the 25th of April

Given 90 days horizon, the Polynomial Regression forecasted value of Axsome Therapeutics on the next trading day is expected to be 70.47 with a mean absolute deviation of 3.44, mean absolute percentage error of 17.43, and the sum of the absolute errors of 209.89.
Please note that although there have been many attempts to predict Axsome Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Axsome Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Axsome Therapeutics Stock Forecast Pattern

Backtest Axsome TherapeuticsAxsome Therapeutics Price PredictionBuy or Sell Advice 

Axsome Therapeutics Forecasted Value

In the context of forecasting Axsome Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Axsome Therapeutics' downside and upside margins for the forecasting period are 67.21 and 73.73, respectively. We have considered Axsome Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
71.17
70.47
Expected Value
73.73
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Axsome Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Axsome Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria120.9687
BiasArithmetic mean of the errors None
MADMean absolute deviation3.4408
MAPEMean absolute percentage error0.0431
SAESum of the absolute errors209.8886
A single variable polynomial regression model attempts to put a curve through the Axsome Therapeutics historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm

Predictive Modules for Axsome Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Axsome Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Axsome Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
69.0272.2775.52
Details
Intrinsic
Valuation
LowRealHigh
65.7788.9292.17
Details
Bollinger
Band Projection (param)
LowMiddleHigh
64.9873.2681.54
Details
16 Analysts
Consensus
LowTargetHigh
105.97116.45129.26
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Axsome Therapeutics. Your research has to be compared to or analyzed against Axsome Therapeutics' peers to derive any actionable benefits. When done correctly, Axsome Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Axsome Therapeutics.

Other Forecasting Options for Axsome Therapeutics

For every potential investor in Axsome, whether a beginner or expert, Axsome Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Axsome Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Axsome. Basic forecasting techniques help filter out the noise by identifying Axsome Therapeutics' price trends.

View Axsome Therapeutics Related Equities

 Risk & Return  Correlation

Axsome Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Axsome Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Axsome Therapeutics' current price.

Axsome Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Axsome Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Axsome Therapeutics shares will generate the highest return on investment. By undertsting and applying Axsome Therapeutics stock market strength indicators, traders can identify Axsome Therapeutics entry and exit signals to maximize returns.

Axsome Therapeutics Risk Indicators

The analysis of Axsome Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Axsome Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting axsome stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Axsome Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axsome Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Axsome Stock

  0.76VKTX Viking Therapeutics Potential GrowthPairCorr
  0.75ELEV Elevation Oncology Earnings Call Next WeekPairCorr
  0.7NRSNW NeuroSense TherapeuticsPairCorr
  0.56XFOR X4 Pharmaceuticals Earnings Call Next WeekPairCorr
  0.54LLY Eli Lilly Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Axsome Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axsome Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axsome Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axsome Therapeutics to buy it.
The correlation of Axsome Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axsome Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axsome Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axsome Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Axsome Therapeutics is a strong investment it is important to analyze Axsome Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Axsome Therapeutics' future performance. For an informed investment choice regarding Axsome Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Axsome Therapeutics to cross-verify your projections.
To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Axsome Stock analysis

When running Axsome Therapeutics' price analysis, check to measure Axsome Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axsome Therapeutics is operating at the current time. Most of Axsome Therapeutics' value examination focuses on studying past and present price action to predict the probability of Axsome Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axsome Therapeutics' price. Additionally, you may evaluate how the addition of Axsome Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Axsome Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axsome Therapeutics. If investors know Axsome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axsome Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.27)
Revenue Per Share
5.957
Quarterly Revenue Growth
1.935
Return On Assets
(0.25)
Return On Equity
(1.59)
The market value of Axsome Therapeutics is measured differently than its book value, which is the value of Axsome that is recorded on the company's balance sheet. Investors also form their own opinion of Axsome Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Axsome Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axsome Therapeutics' market value can be influenced by many factors that don't directly affect Axsome Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axsome Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Axsome Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axsome Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.